{"title":"Weight Loss Support","description":"\u003cp\u003e\u003cstrong\u003eReal Science. Real Results. Real You.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eResearch-grade metabolic and GLP-1 peptides studied for appetite regulation, fat metabolism and body-weight reduction.\u003c\/p\u003e","products":[{"product_id":"semaglutide","title":"Semaglutide","description":"\u003cp\u003eSemaglutide represents a breakthrough in metabolic health support. Originally developed for type 2 diabetes management, this GLP-1 receptor agonist has gained widespread attention for its remarkable effects on body weight and appetite regulation. The compound works by mimicking glucagon-like peptide-1, a hormone your body naturally produces after eating. What sets semaglutide apart from older weight management approaches is its dual action on both the gut and brain. It slows gastric emptying so you feel fuller longer, while simultaneously targeting appetite centers in the hypothalamus to reduce hunger signals. Clinical trials have demonstrated average weight reductions of 15-20% of body weight when combined with lifestyle modifications. Beyond weight loss, semaglutide shows promise for cardiovascular health, with studies indicating reduced risk of major cardiac events in certain populations. The once-weekly dosing schedule offers convenience compared to daily alternatives, though proper titration remains essential for tolerability.\u003c\/p\u003e","brand":"Peptoris Labs","offers":[{"title":"10mg","offer_id":57534599790923,"sku":null,"price":80.0,"currency_code":"GBP","in_stock":true},{"title":"20mg","offer_id":57534599823691,"sku":null,"price":100.0,"currency_code":"GBP","in_stock":true},{"title":"30mg","offer_id":57534599856459,"sku":null,"price":110.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/3599\/8283\/files\/ChatGPTImageJun9_2026_04_39_02PM.png?v=1781020176"},{"product_id":"tirzepatide","title":"Tirzepatide","description":"\u003cp\u003eTirzepatide represents the biggest breakthrough in obesity treatment in decades. Unlike earlier medications that target a single pathway, tirzepatide activates both GIP and GLP-1 receptors simultaneously, producing dramatic effects on appetite, blood sugar, and body weight. In clinical trials, participants lost up to 22.5% of their body weight—results previously achievable only through surgery. FDA-approved as Mounjaro for type 2 diabetes and Zepbound for weight loss, tirzepatide has become one of the most sought-after medications in history, with demand far exceeding supply. The compound works by mimicking natural gut hormones that signal fullness to the brain, reduce appetite, slow gastric emptying, and improve insulin sensitivity.\u003c\/p\u003e","brand":"Peptoris Labs","offers":[{"title":"10mg","offer_id":57559492624715,"sku":null,"price":70.0,"currency_code":"GBP","in_stock":true},{"title":"15mg","offer_id":57534599921995,"sku":null,"price":90.0,"currency_code":"GBP","in_stock":true},{"title":"20mg","offer_id":57534599954763,"sku":null,"price":110.0,"currency_code":"GBP","in_stock":true},{"title":"30mg","offer_id":57534599987531,"sku":null,"price":130.0,"currency_code":"GBP","in_stock":true},{"title":"40mg","offer_id":57534600020299,"sku":null,"price":150.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/3599\/8283\/files\/2_3.png?v=1781017992"},{"product_id":"retatrutide","title":"Retatrutide","description":"\u003cp\u003eRetatrutide (developmental code: LY3437943) is a groundbreaking investigational peptide developed by Eli Lilly that represents the next evolution in obesity and type 2 diabetes pharmacotherapy. Unlike previous weight loss medications that target one or two metabolic pathways, retatrutide is the first triple receptor agonist that simultaneously activates three key hormonal pathways: GLP-1, GIP, and glucagon receptors.\u003c\/p\u003e\u003cp\u003eFirst publicly identified around 2019, retatrutide has generated significant attention in the medical community after demonstrating unprecedented weight loss results in clinical trials—with participants losing up to 24.2% of their body weight in 48 weeks, surpassing the efficacy of current market-leading medications like semaglutide (Wegovy) and tirzepatide (Mounjaro).\u003c\/p\u003e\u003cp\u003eAs obesity affects over 42% of American adults and is linked to numerous comorbidities including cardiovascular disease, type 2 diabetes, and certain cancers, the development of more effective pharmacological interventions like retatrutide addresses a critical public health need.\u003c\/p\u003e","brand":"Peptoris Labs","offers":[{"title":"20mg","offer_id":57534600053067,"sku":null,"price":100.0,"currency_code":"GBP","in_stock":true},{"title":"30mg","offer_id":57534600085835,"sku":null,"price":110.0,"currency_code":"GBP","in_stock":true},{"title":"40mg","offer_id":57534600118603,"sku":null,"price":120.0,"currency_code":"GBP","in_stock":true},{"title":"50mg","offer_id":57534600151371,"sku":null,"price":130.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/3599\/8283\/files\/3_2.png?v=1781007885"},{"product_id":"cagrilintide","title":"Cagrilintide","description":"\u003cp\u003eCagrilintide takes obesity treatment in a different direction by targeting amylin, a hormone co-secreted with insulin from pancreatic beta cells. Amylin naturally promotes satiety, slows gastric emptying, and suppresses glucagon—effects that complement GLP-1 but through distinct pathways. The problem with native amylin is it's short-lived and tends to aggregate. Cagrilintide is an acylated analog designed for once-weekly dosing with improved stability. Alone, it produces meaningful weight loss, but the real excitement is the combination with semaglutide (called CagriSema). Phase 2 trials showed this combination produces weight loss approaching 25%—potentially the most effective obesity treatment ever tested. By hitting both amylin and GLP-1 pathways, you get additive appetite suppression through different brain circuits. Novo Nordisk is racing this through development as the potential successor to Wegovy. Cagrilintide represents the emerging understanding that obesity is a multi-pathway disease requiring multi-pathway treatment.\u003c\/p\u003e","brand":"Peptoris Labs","offers":[{"title":"10mg","offer_id":57534600249675,"sku":null,"price":85.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/3599\/8283\/files\/5_2.png?v=1781008202"},{"product_id":"mots-c","title":"MOTS-c","description":"\u003cp\u003eMOTS-c is a 16-amino acid peptide encoded within the mitochondrial genome, discovered in 2015 by researchers at the University of Southern California. Unlike most peptides derived from nuclear DNA, MOTS-c is expressed from the mitochondrial 12S rRNA gene, making it one of a small class of mitochondrial-derived peptides (MDPs) with systemic signaling functions. Research has shown MOTS-c acts as a metabolic regulator, improving insulin sensitivity, enhancing exercise capacity, and demonstrating effects that mimic caloric restriction—one of the most robust interventions for extending lifespan in animal models. Its decline with age and restoration of youthful phenotypes in aged animals has made it a focus of aging research.\u003c\/p\u003e","brand":"Peptoris Labs","offers":[{"title":"10mg","offer_id":57534600282443,"sku":null,"price":30.0,"currency_code":"GBP","in_stock":true},{"title":"40mg","offer_id":57534600315211,"sku":null,"price":45.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/3599\/8283\/files\/17_2.png?v=1781014333"},{"product_id":"tesamorelin","title":"Tesamorelin","description":"\u003cp\u003eTesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH) consisting of all 44 amino acids of native GHRH with a trans-3-hexenoic acid modification. Marketed under the brand name Egrifta®, tesamorelin is the only GHRH analog currently FDA-approved for therapeutic use—specifically for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. Unlike direct growth hormone administration, tesamorelin stimulates the pituitary gland to produce and release endogenous GH, maintaining physiological feedback mechanisms. Beyond its approved indication, tesamorelin is being actively researched for applications in non-alcoholic fatty liver disease (NAFLD), cognitive function in aging, and metabolic health optimization.\u003c\/p\u003e","brand":"Peptoris Labs","offers":[{"title":"10mg","offer_id":57534683382091,"sku":null,"price":40.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/3599\/8283\/files\/TESAMORELIN_e805f473-a27d-434a-9b3f-8aeabf0ade5b.png?v=1781016575"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/3599\/8283\/collections\/ChatGPT_Image_Jun_9_2026_08_13_03_AM_473fe6e4-56eb-4437-a096-0b57ab66d401.png?v=1781189716","url":"https:\/\/peptorislabs.com\/collections\/weight-loss-support.oembed","provider":"Peptoris Labs","version":"1.0","type":"link"}